166 related articles for article (PubMed ID: 22678828)
1. CXCR6: the role of environment in tumor progression. Challenges for therapy.
La Porta CA
Stem Cell Rev Rep; 2012 Dec; 8(4):1282-5. PubMed ID: 22678828
[TBL] [Abstract][Full Text] [Related]
2. CXCR6 induces prostate cancer progression by the AKT/mammalian target of rapamycin signaling pathway.
Wang J; Lu Y; Wang J; Koch AE; Zhang J; Taichman RS
Cancer Res; 2008 Dec; 68(24):10367-76. PubMed ID: 19074906
[TBL] [Abstract][Full Text] [Related]
3. Irradiation of breast cancer cells enhances CXCL16 ligand expression and induces the migration of natural killer cells expressing the CXCR6 receptor.
Yoon MS; Pham CT; Phan MT; Shin DJ; Jang YY; Park MH; Kim SK; Kim S; Cho D
Cytotherapy; 2016 Dec; 18(12):1532-1542. PubMed ID: 27720639
[TBL] [Abstract][Full Text] [Related]
4. Chemokine axes CXCL12/CXCR4 and CXCL16/CXCR6 correlate with lymph node metastasis in epithelial ovarian carcinoma.
Guo L; Cui ZM; Zhang J; Huang Y
Chin J Cancer; 2011 May; 30(5):336-43. PubMed ID: 21527066
[TBL] [Abstract][Full Text] [Related]
5. CXCL16 and CXCR6 are coexpressed in human lung cancer in vivo and mediate the invasion of lung cancer cell lines in vitro.
Hu W; Liu Y; Zhou W; Si L; Ren L
PLoS One; 2014; 9(6):e99056. PubMed ID: 24897301
[TBL] [Abstract][Full Text] [Related]
6. CXCL16/CXCR6 chemokine signaling mediates breast cancer progression by pERK1/2-dependent mechanisms.
Xiao G; Wang X; Wang J; Zu L; Cheng G; Hao M; Sun X; Xue Y; Lu J; Wang J
Oncotarget; 2015 Jun; 6(16):14165-78. PubMed ID: 25909173
[TBL] [Abstract][Full Text] [Related]
7. The chemokine CXCL16 and its receptor, CXCR6, as markers and promoters of inflammation-associated cancers.
Darash-Yahana M; Gillespie JW; Hewitt SM; Chen YY; Maeda S; Stein I; Singh SP; Bedolla RB; Peled A; Troyer DA; Pikarsky E; Karin M; Farber JM
PLoS One; 2009 Aug; 4(8):e6695. PubMed ID: 19690611
[TBL] [Abstract][Full Text] [Related]
8. Expression of the CXCL12/CXCR4 and CXCL16/CXCR6 axes in cervical intraepithelial neoplasia and cervical cancer.
Huang Y; Zhang J; Cui ZM; Zhao J; Zheng Y
Chin J Cancer; 2013 May; 32(5):289-96. PubMed ID: 22958742
[TBL] [Abstract][Full Text] [Related]
9. Expression and regulation of the chemokine CXCL16 in Crohn's disease and models of intestinal inflammation.
Diegelmann J; Seiderer J; Niess JH; Haller D; Göke B; Reinecker HC; Brand S
Inflamm Bowel Dis; 2010 Nov; 16(11):1871-81. PubMed ID: 20848509
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of CXCL16/CXCR6 expression in patients with prostate cancer.
Ha HK; Lee W; Park HJ; Lee SD; Lee JZ; Chung MK
Mol Med Rep; 2011; 4(3):419-24. PubMed ID: 21468586
[TBL] [Abstract][Full Text] [Related]
11. The chemokine receptor CXCR6 and its ligand CXCL16 are expressed in carcinomas and inhibit proliferation.
Meijer J; Ogink J; Kreike B; Nuyten D; de Visser KE; Roos E
Cancer Res; 2008 Jun; 68(12):4701-8. PubMed ID: 18559516
[TBL] [Abstract][Full Text] [Related]
12. CXCR6 expression in non-small cell lung carcinoma supports metastatic process via modulating metalloproteinases.
Mir H; Singh R; Kloecker GH; Lillard JW; Singh S
Oncotarget; 2015 Apr; 6(12):9985-98. PubMed ID: 25888629
[TBL] [Abstract][Full Text] [Related]
13. CXCL16 and CXCR6 in Ewing sarcoma family tumor.
Na KY; Kim HS; Jung WW; Sung JY; Kalil RK; Kim YW; Park YK
Hum Pathol; 2014 Apr; 45(4):753-60. PubMed ID: 24507753
[TBL] [Abstract][Full Text] [Related]
14. Cutting edge: profile of chemokine receptor expression on human plasma cells accounts for their efficient recruitment to target tissues.
Nakayama T; Hieshima K; Izawa D; Tatsumi Y; Kanamaru A; Yoshie O
J Immunol; 2003 Feb; 170(3):1136-40. PubMed ID: 12538668
[TBL] [Abstract][Full Text] [Related]
15. CXCR6 upregulation contributes to a proinflammatory tumor microenvironment that drives metastasis and poor patient outcomes in hepatocellular carcinoma.
Gao Q; Zhao YJ; Wang XY; Qiu SJ; Shi YH; Sun J; Yi Y; Shi JY; Shi GM; Ding ZB; Xiao YS; Zhao ZH; Zhou J; He XH; Fan J
Cancer Res; 2012 Jul; 72(14):3546-56. PubMed ID: 22710437
[TBL] [Abstract][Full Text] [Related]
16. CXCR6 is expressed in human prostate cancer in vivo and is involved in the in vitro invasion of PC3 and LNCap cells.
Hu W; Zhen X; Xiong B; Wang B; Zhang W; Zhou W
Cancer Sci; 2008 Jul; 99(7):1362-9. PubMed ID: 18452560
[TBL] [Abstract][Full Text] [Related]
17. Wnt5a-Ror2 signaling in mesenchymal stem cells promotes proliferation of gastric cancer cells by activating CXCL16-CXCR6 axis.
Takiguchi G; Nishita M; Kurita K; Kakeji Y; Minami Y
Cancer Sci; 2016 Mar; 107(3):290-7. PubMed ID: 26708384
[TBL] [Abstract][Full Text] [Related]
18. CXCR6/CXCL16 functions as a regulator in metastasis and progression of cancer.
Deng L; Chen N; Li Y; Zheng H; Lei Q
Biochim Biophys Acta; 2010 Aug; 1806(1):42-9. PubMed ID: 20122997
[TBL] [Abstract][Full Text] [Related]
19. Elevated serum CXCL16 is an independent predictor of poor survival in ovarian cancer and may reflect pro-metastatic ADAM protease activity.
Gooden MJ; Wiersma VR; Boerma A; Leffers N; Boezen HM; ten Hoor KA; Hollema H; Walenkamp AM; Daemen T; Nijman HW; Bremer E
Br J Cancer; 2014 Mar; 110(6):1535-44. PubMed ID: 24518602
[TBL] [Abstract][Full Text] [Related]
20. [Role of CXCL16/CXCR6 axis in the metastasis of human prostate cancer].
Zhou WH; Hu WD; Wu ZQ; Zheng XM; Wang BC
Zhonghua Yi Xue Za Zhi; 2010 Apr; 90(14):947-51. PubMed ID: 20646641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]